Back

Adherence to quadruple therapy for heart failure. A single-center experience in LMIC

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 12 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Asif Khan

Peshawar Institute of Cardiology, Peshawar (Pakistan)

7 More presentations in this session

Presentation thumbnail
Temporal trends in guideline-directed medical therapy prescription and 30-day readmission after heart failure hospitalization
Doctor R. Laborante (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Unlocking stability: predictors of clinical stability in patients undergoing intermittent levosimendan infusions for advanced heart failure
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Impact on hospitalisation and safety of high doses of torasemide in advanced or end-stage decompensated heart failure
Doctor T. Castiello (London, GB)
Abstract Slides Video
Presentation thumbnail
Potential cardio-protective role of dapagliflozin in diabetic patients presented with anterior ST-elevation myocardial infarction (STEMI).
Associate Professor A. Ibrahim (Aswan, EG)
Abstract Slides Video
Presentation thumbnail
Use of guideline-directed medical therapy in women hospitalised for decompensated heart failure
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 12

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Initiation and titration of prognostic drug therapy during hospitalization for acute decompensation of heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Effect of improving utilization of guideline-directed medical therapy for heart failure.
thumbnail
Congress Presentation
Optimizing heart failure management: impact of quadruple therapy initiation at discharge following decompensation events in patients with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources